Chandra Bhagat Pharma Limited (BOM:542934)
India flag India · Delayed Price · Currency is INR
63.00
+3.00 (5.00%)
At close: Nov 16, 2026

Chandra Bhagat Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
54.5930.468.5815.39.057.97
Depreciation & Amortization
9.7310.38.824.871.110.38
Other Operating Activities
25.6626.2515.5416.5621.0631.82
Change in Accounts Receivable
-116-186.7235.02-312.6168.184.14
Change in Inventory
22.89-39.879.85204.0150.799.83
Change in Accounts Payable
87.73229.33-42.79101.294.31-101.82
Change in Other Net Operating Assets
-21.5822.55-162.1132.33-101.86171.67
Operating Cash Flow
63.0192.36-57.0961.7652.64123.98
Operating Cash Flow Growth
136.25%--17.31%-57.54%48.86%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-28.07-9.21-12.03-22.82-3.69-1
Sale of Property, Plant & Equipment
--4.5-0.030.12
Other Investing Activities
33.444.86-0.34.293.071.74
Investing Cash Flow
5.37-4.35-7.82-18.53-0.590.85

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--35.63---
Long-Term Debt Issued
-2.855.77---
Total Debt Issued
-14.812.8541.4---
Short-Term Debt Repaid
--46.37--0.04-6.8-12.49
Long-Term Debt Repaid
----44.07-15.8-52.99
Total Debt Repaid
-45.8-46.37--44.11-22.6-65.47
Net Debt Issued (Repaid)
-60.61-43.5341.4-44.11-22.6-65.47
Other Financing Activities
-19.2-20.03-19.48-13.87-21.87-30.76
Financing Cash Flow
-79.81-63.5621.92-57.98-44.47-96.24

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
000--0-0
Net Cash Flow
-11.4324.46-42.99-14.757.5828.6

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
34.9483.15-69.1138.9448.96122.99
Free Cash Flow Growth
143.50%---20.46%-60.19%48.03%
Free Cash Flow Margin
2.01%7.12%-7.61%1.75%4.09%13.07%
Free Cash Flow Per Share
4.6611.02-9.165.166.4916.30
Levered Free Cash Flow
32.0460.82-64.5422.1635.34107.38
Unlevered Free Cash Flow
43.2672.56-53.3130.2148.93126.03

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
18.7818.7817.9612.8721.6428.39
Cash Income Tax Paid
4.014.015.584.562.321.06
Change in Working Capital
-26.9625.36-90.0325.0221.4283.82